Adherence Interventions for HIV Youth Via Text & Cell Phone - Sequential Multiple Assignment Randomized Trial (SMART)
SMART
Adaptive Antiretroviral Therapy Adherence Interventions for Youth Living With HIV Through Text Messaging and Cell Phone Support Embedded Within the Sequential Multiple Assignment Randomized Trial (SMART) Design
1 other identifier
interventional
83
1 country
1
Brief Summary
The purpose of this study is to test an adaptive adherence intervention, which utilizes two mobile health (mHealth) intervention designs, in an effort to promote adherence to antiretroviral therapy (ART) and achieve and maintain viral load (VL) suppression in youth living with HIV (YLH) while increasing understanding of the context for wide-scale implementation of cell phone support (CPS) and text messaging support (SMS), with and without incentives.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hiv-infections
Started Sep 2018
Typical duration for not_applicable hiv-infections
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 12, 2018
CompletedFirst Posted
Study publicly available on registry
May 24, 2018
CompletedStudy Start
First participant enrolled
September 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2022
CompletedResults Posted
Study results publicly available
December 13, 2024
CompletedDecember 13, 2024
December 1, 2024
3.7 years
April 12, 2018
May 30, 2023
December 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Undetectable Viral Load
Percent of participants that have an undetectable HIV Viral Load.
baseline, month 3, month 6, month 9, and month 12
Medication Adherence Rate - 7 Day
Self reported percentage of medication taken in the past 7 days prior to assessment point. Medication adherence rates will be compared between CPS and SMS groups.
baseline, month 3, month 6, month 9, and month 12
Medication Adherence - 30 Days
Self reported percentage of medication taken in the past 30 days prior to assessment point. Medication adherence rates will be compared between CPS and SMS groups.
baseline, month 3, month 6, month 9, and month 12
Study Arms (8)
CPS-Rsp-T
ACTIVE COMPARATORAfter 3 months of intervention, this group of CPS Rsp will receive 3 months of CPS-T intervention followed by SC.
CPS-Rsp-SC
ACTIVE COMPARATORAfter 3 months of intervention, this group of CPS Rsp's intervention will discontinue and they'll receive SC only
CPS-NRsp-I
ACTIVE COMPARATORAfter 3 months of intervention, this group of CPS NRsp will receive 3 months of CPS-I followed by 3 months of CPS-T and 3 months of SC.
CPS-NRsp-SMS-I
ACTIVE COMPARATORAfter 3 months of intervention, this group of CPS NRsp will receive 3 months of SMS-I followed by 3 months of SMS-T and 3 months of SC
SMS-Rsp-T
ACTIVE COMPARATORAfter 3 months of intervention, this group of SMS Rsp will receive 3 months of SMS tapered (SMS-T) intervention followed by SC.
SMS-Rsp-SC
ACTIVE COMPARATORAfter 3 months of intervention, this group of SMS Rsp, intervention will discontinue and they'll receive SC only
SMS-NRsp-CPS-I
ACTIVE COMPARATORAfter 3 months of intervention, this group of SMS NRsp will receive 3 months of CPS-I followed by 3 months CPS-T and 3 months SC
SMS-NRsp-I
ACTIVE COMPARATORAfter 3 months of intervention, this group of SMS NRsp will receive 3 months of SMS-I followed by 3 months of SMS-T and 3 months of SC
Interventions
Assessment of participant's medication adherence and barrier problem solving via phone conversation
Participants will receive a text message, which will be an electronic reminder regarding medication adherence. Participants will then text back a confirmatory response.
Eligibility Criteria
You may qualify if:
- HIV diagnosis
- Viral load ≥ 200 copies/mL within 3 months prior to enrollment or self-reported adherence ≤ 80%
- ART medication regimen prescribed minimum of 3 months prior to eligibility VL or self-reported adherence
- Sole owner of device capable of sending/receiving calls and text messages
- Willingness to permit research team to communicate with their HIV care provider team
You may not qualify if:
- Mental, physical, or emotional capacity prevents completion of protocol as written
- Inability to understand written/spoken English
- Concurrent participant in any adherence behavioral research intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Florida State Universitylead
- Children's Hospital Los Angelescollaborator
- Hunter College of City University of New Yorkcollaborator
- Wayne State Universitycollaborator
Study Sites (1)
The City University of New York
New York, New York, 10018, United States
Related Publications (1)
Belzer ME, MacDonell KK, Ghosh S, Naar S, McAvoy-Banerjea J, Gurung S, Cain D, Fan CA, Parsons JT. Adaptive Antiretroviral Therapy Adherence Interventions for Youth Living With HIV Through Text Message and Cell Phone Support With and Without Incentives: Protocol for a Sequential Multiple Assignment Randomized Trial (SMART). JMIR Res Protoc. 2018 Dec 20;7(12):e11183. doi: 10.2196/11183.
PMID: 30573448DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Sylvie Naar, PhD; Distinguished Endowed Professor
- Organization
- Florida State University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 12, 2018
First Posted
May 24, 2018
Study Start
September 1, 2018
Primary Completion
May 31, 2022
Study Completion
May 31, 2022
Last Updated
December 13, 2024
Results First Posted
December 13, 2024
Record last verified: 2024-12